
Overview
Review the official description and outline of the new G-Rex® Grant Program, which empowers CGT manufacturers with resources and expertise. This $20 million initiative by ScaleReady, Wilson Wolf Manufacturing, Bio-Techne, and CellReady is designed to propel the advancement of cell and gene therapies (CGT).
What this paper found
ScaleReady's G-Rex® Grant Program is a $20,000,000 initiative run with Wilson Wolf, Bio-Techne and CellReady that gives each recipient between $5,000 and $300,000 of materials and services plus free consulting from G-Rex® Optimization Specialists over a collaboration period of up to 18 months. Awards supply G-Rex® well plates and bioreactors including closed system models, the GatheRex Cell Harvest Pump, RUO and GMP reagents and media, the TcBuster transposon system, and process development support. Applicants must work on cell and gene modified cell therapies derived from T cells, NK cells or HSCs and be working towards an IND. Typical deliverables include IND-enabling or amendment data packages and closed system G-Rex® implementation.
Study details
- Institution
- ScaleReady · Wilson Wolf · Bio-Techne · CellReady
- Application area
- Other
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.